Radiation Medicine

A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4 secretion from normal cells. Par-4 is a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed.

Radiation Oncology Visiting Professor

Dr. Bouthaina S. Dabaja, Associate Professor from the University of Texas MD Anderson Cancer Center, Houston, TX, will be visiting the Radiation Medicine Department on June 19th, 2014.

Subscribe to RSS - Radiation Medicine